The PSA conundrum

Archives of Internal Medicine

Volumn 166, Issue 1, 2006, Pages 7-8

  Barry, Michael J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOPSY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; DIAGNOSTIC TEST; EDITORIAL; HUMAN; MORBIDITY; PHYSICIAN; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RISK BENEFIT ANALYSIS; UNITED STATES;

CASE-CONTROL STUDIES; CLINICAL TRIALS; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 30344451663     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.1.7     Document Type: Editorial

References (12)

1. Chan E, Barry MJ, Vernon SW, Ahn C. Physicians and their personal prostate cancer screening practices with prostate specific antigen: a national survey. J Gen Intern Med. In press.
2. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute. Available at: http://seer.cancer.gov.csr /1975_2002/. Accessed July 19, 2005.
3. McNaughton-Collins M, Fowler FJ Jr, Caubet JF, et al. J. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004;117:719-725.
4. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977-1984.
5. Shaw PA, Etzioni R, Zeliadt SB, et al. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. Am J Epidemiol. 2004;160:1059-1069.
6. Oliver SE, Gunnell D, Donovan JL. Comparison of trends in prostate-cancer mortality in England and Wales and the USA [letter]. Lancet. 2000;355:1788-1789.
7. Concato J, Wells CK, Horwitz RI, et al. The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med. 2006;166:38-43.
8. Kopec JA, Goel V, Bunting PS, et al. Screening with prostate specific antigen and metastatic prostate cancer risk. J Urol. 2005;174:495-499.
9. Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet. 1991;337:1526-1529.
10. Jacobsen SJ, Bergstralh EJ, Katusic SK, et al. Screening digital rectal examination and prostate cancer mortality. Urology. 1998;52:173-179.
11. Andriole GL, Levin DL, Crawford ED, et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial . J Natl Cancer Inst. 2005;97:433-438.
12. Schroder FH, Denis LJ, Roobol M, et al. The story of the European randomized study of screening for prostate cancer. BJU Int. 2003;92(suppl 2):1-13.